Analytical testing for veterinary medicines aligned to VMD (UK) and EMA expectations — companion-animal and livestock products. Identity, potency, impurities, residues, microbial limits and stability for tablets, premixes, oral liquids, injectables and topicals.
Identity, assay and content uniformity for veterinary dosage forms
Related substances and degradation product profiling
Premix and feed-additive homogeneity and stability
Microbial limits and preservative-efficacy testing
Residual solvents and elemental impurities
Stability-indicating method development for VMD / EMA dossiers
Withdrawal-period supportive analytics on referral
Forced-degradation and photostability studies
Active-ingredient assay, related substances and content uniformity.
Trace-level impurity and metabolite quantification.
Residual solvents per ICH Q3C.
Elemental impurities to ICH Q3D / VMD expectations.
USP Apparatus 1, 2 with auto-sampling for veterinary tablets and capsules.
TAMC, TYMC and specified-organism testing per Ph. Eur. 2.6.12 / 2.6.13.
Methods, documentation and acceptance criteria are designed to align with the standards below. This describes design intent — formal accreditations are listed on the About page.
CoA aligned to VMD / EMA specification
Method validation / verification report
Stability summary with shelf-life recommendation
Premix homogeneity study report
Investigation reports for OOS / OOT events
Inspection-ready raw data
Send a short scope and we'll come back with a quote and indicative timeline within one working day.